Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

John G Doench1, Nicolo Fusi2, Meagan Sullender1

  • 1Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

Nature Biotechnology
|January 19, 2016
PubMed